Juliano André Boquett

Dr. Juliano André Boquett

University of California, San Francisco, San Francisco, California, USA
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Neuroimmunomodulation
Verified
Journal Article
Open access
PDF file
PVPriscila Vianna
Priscila Vianna
JGJulia Do Amaral Gomes
Julia Do Amaral Gomes
Juliano André BoquettJuliano André Boquett
Juliano André Boquett
LFLucas Rosa Fraga
Lucas Rosa Fraga
JSJaqueline Schuch
Jaqueline Schuch
LSLavinia Schuler-Faccini
Lavinia Schuler-Faccini
The recent outbreak of the Zika virus (ZIKV) and the discovery that perinatal Zika exposure can lead to the Congenital Zika Syndrome has promoted a call for prevention measures. Due to the increased number of babies born with microcephaly, structural brain abnormalities, and neurological alterations in regions affected by ZIKV, investigations were carried out in order to better understand this process. The maternal immune system directly influences the fetal central nervous system, and complications during pregnancy have been associated with neurodevelopmental disorders. Autism spectrum disorder (ASD), a neurodevelopmental disorder commonly manifested in the first years of life, is a disease with multifactorial etiology and is manifested typically by social and communication impairments, as well as stereotyped behaviors. Brain abnormalities, including both anatomically and functionally, can be observed in this disorder, suggesting delays in neuronal maturation and altered brain connectivity. It is known that some viral congenital infections, such as rubella, and cytomegalovirus can interfere with brain development, being associated with brain calcification, microcephaly, and ASD. Here, we reviewed a range of studies evaluating the aspects concerning brain development, immunological status during pregnancy, and neuroimmunomodulation in congenital viral infections, and we discuss if the fetal brain infection caused by ZIKV could predispose to ASD. Finally, we suggest a mechanism encompassing neurological and immunological pathways that could play a role in the development of ASD in infants after ZIKV infection in pregnancy.

17 January 2014 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
LFL. R. Fraga
L. R. Fraga
CDC. G. Dutra
C. G. Dutra
Juliano André BoquettJuliano André Boquett
Juliano André Boquett
FVF. S. L. Vianna
F. S. L. Vianna
RGR. O. Gonçalves
R. O. Gonçalves
LSLavinia Schuler-Faccini
Lavinia Schuler-Faccini

8 March 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
LSLavinia Schuler-Faccini
Lavinia Schuler-Faccini
MCMiguel del Campo
Miguel del Campo
AGAlfredo García-Alix
Alfredo García-Alix
LVLiana O. Ventura
Liana O. Ventura
Juliano André BoquettJuliano André Boquett
Juliano André Boquett
DSDiogo O. Souza
Diogo O. Souza
Five years after the identification of Zika virus as a human teratogen, we reviewed the early clinical manifestations, collectively called congenital Zika syndrome (CZS). Children with CZS have a very poor prognosis with extremely low performance in motor, cognitive, and language development domains, and practically all feature severe forms of cerebral palsy. However, these manifestations are the tip of the iceberg, with some children presenting milder forms of deficits. Additionally, neurodevelopment can be in the normal range in the majority of the non-microcephalic children born without brain or eye abnormalities. Vertical transmission and the resulting disruption in development of the brain are much less frequent when maternal infection occurs in the second half of the pregnancy. Experimental studies have alerted to the possibility of other behavioral outcomes both in prenatally infected children and in postnatal and adult infections. Cofactors play a vital role in the development of CZS and involve genetic, environmental, nutritional, and social determinants leading to the asymmetric distribution of cases. Some of these social variables also limit access to multidisciplinary professional treatment.

22 August 2017 in Reproduction, Fertility and Development
Verified
Journal Article
Closed access
PDF file
MFMarcela Felix Fortis
Marcela Felix Fortis
LFLucas Rosa Fraga
Lucas Rosa Fraga
Juliano André BoquettJuliano André Boquett
Juliano André Boquett
TKThayne Kowalski
Thayne Kowalski
CDCaroline Gross Dutra
Caroline Gross Dutra
MSMaria Teresa Vieira Sanseverino
Maria Teresa Vieira Sanseverino
Recurrent pregnancy loss (RPL) affects ~3–5% of couples attempting to conceive and in around 50% of cases the aetiology remains unknown. Adequate vascularisation and placental circulation are indispensable for the development of a normal pregnancy. Prostaglandin-endoperoxide synthase 2 (PTGS2), vascular endothelial growth factor (VEGF) and the nitric oxide (NO) systems play important roles in reproductive physiology, participating in several steps including implantation and apoptosis of trophoblast cells. In this study we evaluated genetic polymorphisms in the inducible nitric oxide synthase (NOS2), PTGS2 and VEGFA genes as susceptibility factors for RPL. A case-control study was conducted in 149 women having two or more miscarriages and 208 controls. Allele and genotype distributions of the polymorphisms studied in the two groups were not statistically different. However, the dominant model showed that the presence of variant T (TT/GT) of rs2779249 (-1290G > T) of NOS2 was significantly associated with RPL (OR = 1.58, CI 95% = 1.03–2.44; P = 0.037). The increased risk remained significant when adjusted for number of pregnancies, alcohol consumption and ethnicity (OR = 1.92, CI95% = 1.18–3.11; P = 0.008). These results suggest that the variant genotypes of the functional polymorphism rs2779249 in the NOS2 promoter are a potential risk for RPL, possibly due to oxidative stress mechanisms.

9 October 2019 in HLA
Verified
Journal Article
Closed access
PDF file
Juliano André BoquettJuliano André Boquett
Juliano André Boquett
RBRafael Bisso‐Machado
Rafael Bisso‐Machado
MZMarcelo Zagonel‐Oliveira
Marcelo Zagonel‐Oliveira
LSLavinia Schuler-Faccini
Lavinia Schuler-Faccini
NFNelson J. R. Fagundes
Nelson J. R. Fagundes

1 January 2013 in Genetics and Molecular Research
Verified
Journal Article
Closed access
Juliano André BoquettJuliano André Boquett
Juliano André Boquett
JAJ.R.P. Alves
J.R.P. Alves
COCarlos Oliveira
Carlos Oliveira
The chimeric oncogene BCR/ABL, which is the product of reciprocal translocation between chromosomes 9 and 22, is a known molecular marker of chronic myeloid leukemia (CML), and is related to the major factors involved in leukemogenesis. Some previous studies have also reported the presence of this oncogene in peripheral blood cells of healthy individuals. In this study, we investigated the presence of BCR/ABL transcripts in peripheral blood of individuals aged 40 years or more without symptoms of CML. The presence of BCR/ABL transcripts was observed in 2 of the 30 individuals analyzed. The genesis of BCR/ABL transcripts and its presence in healthy individuals are topics of ongoing debate. The risks and biological implications of the presence of BCR/ABL transcripts in healthy individuals are challenging issues that remain to be elucidated.